A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
A Phase 1, Open-Label Study to Evaluate the Mutual Drug-Drug Interaction Potential Between Denifanstat and Resmetirom in Healthy Adult Participants
Sponsor: Sagimet Biosciences Inc.
Listed as NCT07216313, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Sagimet Biosciences Inc., it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Nov 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE1
First recorded
Sep 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sagimet Biosciences Inc.
For direct contact, visit the study record on ClinicalTrials.gov .